Goodwin Investment Advisory’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Goodwin Investment Advisory's AXSM Position: Q3 2026 in Review
Goodwin Investment Advisory held its Axsome Therapeutics (AXSM) position steady in Q3 2026 at 4,241 shares worth $782K. The position accounts for 0.27% of the portfolio, ranked #35.
Goodwin Investment Advisory first reported a position in AXSM in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.04M in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Goodwin Investment Advisory held 4,241 shares of Axsome Therapeutics worth $782K as of Q3 2026.
- Goodwin Investment Advisory left its Axsome Therapeutics share count unchanged in Q3 2026.
- Axsome Therapeutics made up 0.27% of Goodwin Investment Advisory's portfolio in Q3 2026, its #35 holding.
- Goodwin Investment Advisory first reported a position in Axsome Therapeutics in Q1 2024 and has held it in 11 quarters since.
- Goodwin Investment Advisory's Axsome Therapeutics position peaked at $1.04M in Q2 2026.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Goodwin Investment Advisory's 13F filing for Q3 2026, filed 16 Nov 2026.